Long-term oral anticoagulant therapy in elderly patients
- PMID: 3149144
- DOI: 10.1093/ageing/17.6.388
Long-term oral anticoagulant therapy in elderly patients
Abstract
Forty-nine patients aged 65-89 years, treated for 6 months-6 years (mean 3.9 years) over a total of 195 patient years, were studied. The efficacy of anticoagulant control or the occurrence of complications or treatment failures did not vary with the age, sex, social status, mobility, visual acuity, domiciliary supervision of medication or the indication for anticoagulation. A significant correlation was observed between the concomitant drug therapy and anticoagulant control (P less than 0.001) but not with the occurrence of complications and treatment failures. Poor anticoagulant control was observed particularly in those receiving drugs known to potentiate warfarin effect and in whom more changes were made to their concomitant drug therapy. Five patients who experienced six non-fatal haemorrhages (two major and four minor) showed poor overall anticoagulant control from the outset (P less than 0.01). The treatment failure rate was 4%.
Similar articles
-
A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.Chest. 2005 Mar;127(3):922-7. doi: 10.1378/chest.127.3.922. Chest. 2005. PMID: 15764777
-
Determinants of anticoagulant control in patients receiving warfarin.Br J Clin Pharmacol. 1977 Jun;4(3):309-14. doi: 10.1111/j.1365-2125.1977.tb00718.x. Br J Clin Pharmacol. 1977. PMID: 901698 Free PMC article.
-
The effect of two synthetic anticoagulant drugs (coumarin and inandione) in the ewe.Res Vet Sci. 1971 Mar;12(2):106-12. Res Vet Sci. 1971. PMID: 5572531 No abstract available.
-
Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.Can J Cardiol. 2013 Jul;29(7 Suppl):S34-44. doi: 10.1016/j.cjca.2013.04.013. Can J Cardiol. 2013. PMID: 23790596 Review.
-
Left atrial appendage closure is preferred to chronic warfarin therapy: the pro perspective.Card Electrophysiol Clin. 2015 Sep;7(3):403-13. doi: 10.1016/j.ccep.2015.05.019. Epub 2015 Jul 10. Card Electrophysiol Clin. 2015. PMID: 26304519 Review.
Cited by
-
Factors affecting the maintenance dose of warfarin.J Clin Pathol. 1993 Apr;46(4):382-3. doi: 10.1136/jcp.46.4.382-c. J Clin Pathol. 1993. PMID: 8338590 Free PMC article. No abstract available.
-
Platelet dysfunction in thrombosis patients treated with vitamin K antagonists and recurrent bleeding.PLoS One. 2013 May 28;8(5):e64112. doi: 10.1371/journal.pone.0064112. Print 2013. PLoS One. 2013. PMID: 23724024 Free PMC article.
-
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012 Feb;141(2 Suppl):e44S-e88S. doi: 10.1378/chest.11-2292. Chest. 2012. PMID: 22315269 Free PMC article. Review.
-
Safety of anticoagulation in the elderly: reasons for discontinuing therapy.Postgrad Med J. 1992 Oct;68(804):824-8. doi: 10.1136/pgmj.68.804.824. Postgrad Med J. 1992. PMID: 1461856 Free PMC article.
-
Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.Br J Gen Pract. 1995 Mar;45(392):153-8. Br J Gen Pract. 1995. PMID: 7772394 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical